Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gola Planta Gel is a topical herbal formulation developed by ORENDA (Orenda Pharma) specifically for the management of inflammatory and irritative conditions of the oropharyngeal mucosa. The product is composed of a synergistic blend of plant extracts, typically including *Plantago lanceolata* (Ribwort plantain), *Aloe vera*, and *Althaea officinalis* (Marshmallow), often enriched with propolis. Its primary mechanism of action involves the formation of a mucoadhesive protective film over the oral and pharyngeal lining. This mechanical barrier shields the sensitive mucosa from external irritants, pathogens, and chemical triggers, thereby reducing pain and inflammation while facilitating the natural healing process. It is indicated for the symptomatic relief of sore throat, pharyngitis, and oral lesions such as stomatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gola Planta Gel.